Professional Documents
Culture Documents
Textbook Drugs in Neurology 1St Edition Sathiji Nageshwaran Ebook All Chapter PDF
Textbook Drugs in Neurology 1St Edition Sathiji Nageshwaran Ebook All Chapter PDF
Nageshwaran
Visit to download the full and correct content document:
https://textbookfull.com/product/drugs-in-neurology-1st-edition-sathiji-nageshwaran/
More products digital (pdf, epub, mobi) instant
download maybe you interests ...
https://textbookfull.com/product/kaufman-s-clinical-neurology-
for-psychiatrists-major-problems-in-neurology-9th-edition-
kaufman-md/
https://textbookfull.com/product/drugs-in-american-society-erich-
goode/
https://textbookfull.com/product/mksap-neurology-patrick-c-
alguire-editor-in-chief/
https://textbookfull.com/product/drugs-in-sport-seventh-edition-
david-r-mottram/
Mount Sinai expert guides Neurology 1st Edition
Motiwala
https://textbookfull.com/product/mount-sinai-expert-guides-
neurology-1st-edition-motiwala/
https://textbookfull.com/product/the-hospital-neurology-book-1st-
edition-arash-salardini/
https://textbookfull.com/product/harrisons-neurology-in-clinical-
medicine-4th-edition-stephen-l-hauser/
https://textbookfull.com/product/drugs-in-anaesthesia-and-
intensive-care-5th-edition-scarth/
https://textbookfull.com/product/advances-in-neuropharmacology-
drugs-and-therapeutics-1st-edition-md-sahab-uddin-editor/
OXFORD MEDICAL PUBLICATIONS
Drugs in Neurology
Drugs
in Neurology
Edited by
Sathiji Nageshwaran
Wellcome Trust Translational Medicine and Therapeutics
Fellow, Imperial College London, UK; Honorary Clinical
Fellow in Neurology, National Hospital for Neurology and
Neurosurgery, Queen Square, London, UK
David Ledingham
Neurology Registrar, Department of Neurology, Royal
Victoria Infirmary, Newcastle Upon Tyne, UK
Heather C Wilson
Consultant Neurologist and Honorary Clinical
Lecturer, Royal Free London NHS Trust, UK; Honorary
Consultant Neurologist, National Hospital for Neurology
and Neurosurgery, Queen Square, London, UK
Associate Editor
Anthony Dickenson
Professor of Neuropharmacology, Neuroscience,
Physiology, and Pharmacology, University College
London, UK
1
1
Great Clarendon Street, Oxford, OX2 6DP,
United Kingdom
Oxford University Press is a department of the University of Oxford.
It furthers the University’s objective of excellence in research, scholarship,
and education by publishing worldwide. Oxford is a registered trade mark of
Oxford University Press in the UK and in certain other countries
© Oxford University Press 2017
The moral rights of the authors have been asserted
First Edition published 2017
Impression: 1
All rights reserved. No part of this publication may be reproduced, stored in
a retrieval system, or transmitted, in any form or by any means, without the
prior permission in writing of Oxford University Press, or as expressly permitted
by law, by licence or under terms agreed with the appropriate reprographics
rights organization. Enquiries concerning reproduction outside the scope of the
above should be sent to the Rights Department, Oxford University Press, at the
address above
You must not circulate this work in any other form
and you must impose this same condition on any acquirer
Published in the United States of America by Oxford University Press
198 Madison Avenue, New York, NY 10016, United States of America
British Library Cataloguing in Publication Data
Data available
Library of Congress Control Number: 2016936824
ISBN 978–0–19–966436–8
Printed and bound in China by
C&C Offset Printing Co., Ltd.
Oxford University Press makes no representation, express or implied, that the
drug dosages in this book are correct. Readers must therefore always check
the product information and clinical procedures with the most up-to-date
published product information and data sheets provided by the manufacturers
and the most recent codes of conduct and safety regulations. The authors and
the publishers do not accept responsibility or legal liability for any errors in the
text or for the misuse or misapplication of material in this work. Except where
otherwise stated, drug dosages and recommendations are for the non-pregnant
adult who is not breast-feeding
Links to third party websites are provided by Oxford in good faith and
for information only. Oxford disclaims any responsibility for the materials
contained in any third party website referenced in this work.
The authors have offered brand names in certain places in this book to assist the
reader. This does not constitute a recommendation for those brands and other
brands may be available.
v
Foreword by Professor
Matthews
The amount of information that neurologists need for safe and effective
practice has grown rapidly over the last generation as neurology has moved
from a focus on diagnosis to one on treatment. As a consequence of this,
the busy general neurologist or trainee faces new challenges in managing
pharmacological treatments. This practical handbook, with its succinct sum-
maries of widely accepted management approaches to diseases commonly
encountered, and well-set out, detailed information on individual drugs,
goes a long way towards addressing this challenge. It will be a welcome
addition to my clinic desk.
Nageshwaran, Ledingham and Wilson have brought a range of experi-
ence to developing a text that will help doctors with very different lev-
els of expertise. For those in training or approaching an area with which
they are less familiar, the short chapters describing common syndromes
and their management provides a quick review. While a sub-specialist might
quibble with details, the approaches are sensible and reflect mainstream
British practice. Particularly welcome are the well-selected references to
the evidence base for treatments. These include the key points needed to
explain to patients why they are being treated to engage them as a first step
towards enabling them to be a full partners in their disease management.
For more experienced neurologists, the tables comparing pharmacologi-
cal characteristics and the associated reminders of drug monitoring require-
ments and interactions provide important, practical aids to better practice.
I find the pharmacokinetic data especially useful. Like all of the other data
pulled together here, while available elsewhere, it can be difficult to access
quickly when it is needed. The range of data summarised has been chosen
thoughtfully. The tables also are set out well and in a typeface that doesn’t
challenge the aging neurologist’s eyesight!
The role of reference books in an age of apps is increasingly questioned.
This volume illustrates why there is still a place for the book. It is well edited,
providing information selected to address practical clinical problems by a
group of authors aware of the needs of both trainees and experienced
clinicians who have “seen it all”. As another volume in a respected series,
the reader can have confidence in the quality of the data. Finally, it is organ-
ised to suit needs of everyday practice, even to the extent that the early
chapters are arranged in approximate order of the frequency with which
the problems arise in usual clinic practice.
The authors are to be congratulated!
Paul M. Matthews, OBE, MD,
D Phil, FRCP, FMedSci
Imperial College London, 2016
vi
Foreword by Professor
Bronstein
There are several roles practicing clinicians play in caring for patients but
none are more essential than providing an accurate diagnosis and prescrib-
ing the appropriate treatments. Neurological disorders have often been
seen as some of the most challenging especially to the general practitioner
and non-neurologist. Furthermore, there has been an explosion in our
understanding of neurological disease over the past few decades making the
task of providing high-level care even more daunting. Clinical-pathological
phenotypes have been much better refined with the development of
advanced imaging techniques and genetics. The sub-specialization of neu-
rology has also grown in recent years with this improved understanding
of the pathophysiology of common and rare neurological disorders. With
these advances came new medications and repurposing of older medica-
tions. The sheer volume of information that a clinician must assimilate has
become overwhelming.
How we find medical information has also changed over the past few
decades. When I worked in Nicaragua 25 years ago, there were essentially
no resources covering neurological disease and treatment beyond what I
could carry. Conversely, while studying at the National Hospital in London,
the library was overflowing with reference books and journals. Reviewing
and filtering the massive amount of information was exciting but time con-
suming and not very practical for a practicing clinician. The Internet has
provided an even larger array of information on neurological disorders and
treatments but it also comes with important cautions. The accuracy and
reliability of Internet sources always has to be considered and is not always
clear despite thorough investigation.
Drugs in Neurology is a wonderful practical resource to help manage the
massive amount of critical information needed to be an effective practicing
clinician. The book is divided into two sections. The first section provides an
up to date but succinct description of clinical conditions and approaches to
management. There is a clear emphasis on evidence-based medicine. The
second section of this book contains comprehensive specific information
on classes of medications and specific drugs which are organized alpha-
betically. Included are details on mechanism of actions, pharmacokinetics
and interactions, toxicity and side effects, contraindications, and evidence
of efficacy. Tables are effectively used for drug comparisons and pertinent
references are provided.
This book will find a place in my doctor’s bag and will be helpful for any
clinician treating patients with neurological conditions. This succinct, well-
organized Internet-independent resource will find plenty of use both in the
outpatient clinic and during inpatient hospital rounds.
Jeff Bronstein MD, PhD
David Geffen School of Medicine at UCLA
Los Angeles, 2016
vii
Preface
A new era in clinical neurology is under way. In recent years, neurology has
seen a shift in practice; many hitherto incurable neurological conditions can
now be effectively treated. Thanks to new insights into pathophysiology,
improved diagnostic tools, and a focus on translational research increasingly
efficacious treatments are emerging.
With the rapidly evolving pharmacopeia used in modern neurology,
there is now a need for a practical guide which provides an evidence-based
approach enabling the user to choose the most appropriate therapy for the
increasingly wide range of neurological conditions amenable to treatment.
Drugs in Neurology comprehensively covers the modern management of
neurological diseases in adults. Emphasis is placed on the pharmacological
underpinnings behind the drugs used and on the evidence base for their
use, but respect is also given to treatment recommendations established
as a result of decades of clinical experience and to opinions from experts
in the field.
We hope this book will be of value to trainees in neurology and clini-
cal pharmacology and to all those involved in the treatment of adults with
neurological disorders.
We welcome comments and feedback from readers to help refine subse-
quent print and online editions of Drugs in Neurology.
Please e-mail all correspondence to: editors.drugsinneurology@gmail.
com.
viii
Dedication
Acknowledgements
This work would not have been possible without the understanding and
support of our families.
SN would like to thank his incredible mentors in clinical neuroscience that
have supported him throughout his career: Dr Heather Wilson, Miss Joan
Grieve, Dr Yvette Bordelon, and Professor Susan Perlman.
DL would like to thank his (equally incredible) mentors, past and present
and the book’s contributors, whose hard work forms the core of this book
and who tolerated numerous queries and revisions (for the most part in
good humour).
HW would like to thank all her colleagues and friends in the Neurology
Department at the Royal Free Hospital who have inspired and supported
her throughout her career. And in memory of George Harwood who will
always be her greatest role model.
We would like to extend our sincere gratitude to OUP for their patience
and guidance during the production of this book, in particular our commis-
sioning editors Peter Stevenson and Lauren Dunn. It has been a long road,
but we got there!
xi
Contents
Contributors xiii
Symbols and abbreviations xvi
How to use this book xxvii
Index 643
xiii
Contributors
M website
7 approximately
° degree
= equal to
> greater than
< less than
≥ equal to or greater than
≤ equal to or less than
± plus or minus
α alpha
β beta
δ delta
γ gamma
κ kappa
μ mu
% per cent
£ pound sterling
®
registered trademark
4-AP 4-aminopyridine
A&E accident and emergency
AAN American Academy of Neurology
AbESSTT Abciximab in Emergency Treatment of Stroke Trial
ABN Association of British Neurologists
ACE angiotensin-converting enzyme
AChEI anticholinesterase inhibitor
AChR acetylcholine receptor
AD autosomal dominant; Alzheimer’s disease
ADAS-Cog Alzheimer’s Disease Assessment Scale cognitive subscale
ADCS-ADL Alzheimer’s Disease Cooperative Study Activities of
Daily Living
ADEM acute disseminated encephalomyelitis
ADH antidiuretic hormone
ADHD attention-deficit/hyperactivity disorder
ADP adenosine diphosphate
AED antiepileptic drugs
AF atrial fibrillation
SYMBOLS AND ABBREVIATIONS xvii
DM dermatomyositis
DM1 myotonic dystrophy type 1
DM2 myotonic dystrophy type 2
DMD Duchenne muscular dystrophy
DML distal motor latency
DMPS 2,3-dimercapto-1-propane sulfonate
DMSA dimercaptosuccinic acid
DMT disease-modifying therapy
DNA deoxyribonucleic acid
DOPAC 3,4-dihydroxyphenylacetic acid
DRD dopa-responsive dystonia
DRT dopaminergic replacement therapy
DSM-IV Diagnostic and Statistical Manual of Mental Disorders,
fourth edition
dTT diluted thrombin time
DWI diffusion-weighted imaging
EA1 episodic ataxia type 1
EA2 episodic ataxia type 2
EBV Epstein–Barr virus
ECG electrocardiogram
ECT ecarin clotting time
EDSS Expanded Disability Status Scale
EDTA ethylenediaminetetraacetic acid
EEG electroencephalogram
EFNS European Federation of Neurological Societies
eGFR estimated glomerular filtration rate
EMG electromyography
ENS European Neurological Society
ERT enzyme replacement therapy
ESR erythrocyte sedimentation rate
ESRS European Sleep Research Society
ET essential tremor
EU European Union
EULAR European League Against Rheumatism
EXPRESS EXelon in PaRkinson’s disEaSe dementia Study
FBC full blood count
FDA Food and Drug Administration
FLAIR fluid-attenuated inversion recovery
ft foot
FTD frontotemporal dementia
xx SYMBOLS AND ABBREVIATIONS
RR relative risk
RRMS relapsing–remitting multiple sclerosis
rt-PA recombinant tissue plasminogen activator
s second
SACD subacute combined degeneration of the cord
SAH subarachnoid haemorrhage
SANAD Standard And New Antiepileptic Drugs (study)
SC subcutaneous
SCA spinocerebellar ataxia
SCLC small cell lung cancer
SD standard deviation
SIADH syndrome of inappropriate antidiuretic hormone
SLE systemic lupus erythematosus
SMD standardized mean difference
SNAP-25 synaptosome-associated protein-25
SNRI serotonin and noradrenaline reuptake inhibitor
SPARCL Stroke Prevention by Aggressive Reduction in
Cholesterol Levels (trial)
SPMS secondary progressive multiple sclerosis
spp. species
SRT stereotactic radiosurgical technique
SSRI selective serotonin reuptake inhibitor
STN subthalamic nucleus
SUNCT short-lasting unilateral neuralgiform headache attacks
with conjunctival injection and tearing
TA tranexamic acid
TAC trigeminal autonomic cephalalgia
TAN tropical ataxic neuropathy
TB tuberculosis
TBZ tetrabenazine
TCA tricyclic antidepressant
tds three times daily
TEN toxic epidermal necrolysis
TFT thyroid function test
Th2 T helper 2
THC delta-9-tetrahydrocannabinol
TIA transient ischaemic attack
TM transverse myelitis
Tmax maximum plasma concentration
TNF tumour necrosis factor
TOP Tysabri Observational Program
xxvi SYMBOLS AND ABBREVIATIONS
Drugs in Neurology includes clinical and prescribing information for over 180
drugs. It is split into two sections. The first half of the book contains chap-
ters covering the major neurological sub-specialties and common neurologi-
cal symptoms. The second half comprises individual drug monographs for
all the major agents used in neurology, listed in an easily accessible A–Z
format.
In the sub-specialty chapters, all treatable conditions likely to be encoun-
tered in adult neurological practice are included. A brief discussion of core
clinical features, all recommended treatments, and a synthesis of the evi-
dence base for each treatment are outlined for each condition.
In the A–Z section, monographs are provided for individual drugs and
also for relevant drug classes. Each monograph contains licensing infor-
mation (UK, USA, and off-license uses), details of available formulations
(generic and brands), and mechanism(s) of action.
Toxicity and side effects are outlined in the individual drug sections, or in
the associated drug class monographs if they are shared with other similar
drugs. Common and severe side effects are highlighted, but side effects con-
sidered both common and severe are placed only in the severe category to
avoid duplication. Dose adjustments or restrictions recommended in renal
and hepatic impairment, the elderly, pregnancy, and breastfeeding are also
included.
Efficacy data are given, along with the evidence base for each condition,
with a focus on key trials and meta-analyses, which are referenced. Where
evidence is lacking, this is stated. Finally, practical information facilitating
safe use of the medication is provided. This includes dosing and monitoring
guidelines, and details of pharmacokinetics and interactions.
Disclaimer
Every effort has been made to ensure the accuracy of the information
presented within this text, with use of manufacturers’ guidance, official
guidelines, and recognized drug formularies such as the British National
Formulary. However, the text should not be used as a substitute to the most
up-to-date published guidance, and national and local formularies.
Another random document with
no related content on Scribd:
quick! Take a look and see if ye can sight a sail. [Kanaka shins quickly up
the bole of the coco palm to the top and looks out on all sides of him. The
others rise painfully to their feet and gaze up at him with awakened hope.]
Jimmy—[Suddenly, in a glad voice.] I see um—see sail, Captain.
Cates—[Waving his arms frenziedly.] Sail—ho!
Jimmy—Look plenty like trade schooner, Captain. She no change course
she fetch plenty close by here. She make full sail, she got plenty fella wind
out there, she come quick.
Horne—[Clapping Cates on the back.] Headin’ straight for us, Cates,
d’you hear?
Bartlett—How far d’ye reckon she be?
Jimmy—She’s five, six fella mile, Captain.
Bartlett—Come down. [The Islander slides down. Bartlett exclaims
exultantly.] Didn’t I tell ye? In the nick o’ time. When she makes in close
we’ll go down to the reef and yell and wave at her. They’ll see! The luck’s
with us today! [His eyes fall on the treasure and he starts.] But now—
what’s to do with this chest—the gold?
Horne—[Quickly.] You ain’t going to tell them on the schooner about
it?
Cates—They’d claim to share with us.
Horne—More like they’d steal it and knife us in the bargain. I know the
kind on them schooners.
Bartlett—[Scornfully.] D’ye think I’m cracked? No, we’ll bury it here.
Cates—[Regretfully.] Leave it behind for anyone to find?
Bartlett—We’ll bury it deep, where hell itself won’t find it—and we’ll
make a map o’ this island. [He takes a sheet of paper and a stub of pencil
from his pocket—pointing to the foot of the tree.] Dig a hole here—you,
Horne and Jimmy—and dig it deep. [The two head down and commence to
hollow out the sand with their hands. Bartlett draws on the paper.]
There’s the lagoon—and the reef—and here’s this tree—the only one on the
island—’twould be hard to miss. [To Cates, who is peering over his
shoulder.] And here where the tree is, d’ye see, Cates, I’ll make a cross
where the gold is hid.
Horne—[Over his shoulder, without ceasing his work.] How d’ye know
the lay o’ this island—to find it again?
Bartlett—By the last reckonin’ o’ the Triton’s. It’s writ on a page I
tore from the log-book. And from there we headed due north in the boat,
unless the compass lied—four days—a hundred and fifty miles, I reckon.
[Exultantly.] Oh, all hell’d not stop me from findin’ this place again when I
know the gold’s here. Let us once get home and I’ll fit out a small schooner
the four of us can sail, and we’ll come back here to dig it up. It won’t be
long, I swear to ye!
Horne—[Straightening up.] This deep enough, sir?
Bartlett—It looks to be.
Jimmy—[Who has straightened up and is looking off left—suddenly
points excitedly.] He look, Captain! Cook fella, he look here! Boy he look,
too! They look plenty too much, Captain! [All four stand staring off at
Butler and the boy, whose presence on the island they have forgotten in
their mad excitement.]
Cates—[In stupid dismay.] They’ll know where it’s hid, sir!
Horne—They’ll tell ’em on the schooner!
Cates—[Wildly.] We’ve got to do for ’em, Captain! Gimme your knife,
Jimmy—your knife—— [He stumbles toward the Islander, who pushes him
aside brusquely, looking questioningly toward the Captain.]
Bartlett—[Who has been standing motionless, as if stunned by this
forgotten complication—slowly.] There they be watchin’ us, the sneakin’
dogs! Sit down, an’ they won’t see. [They all squat in the sand.] I was
forgettin’ they was here. [Striking his knee with clenched fist.] We’ve got to
do somethin’ damn quick! That schooner’ll be up soon where they kin sight
her—and they’ll wave and yell then—and she’ll see ’em!
Horne—And good-bye to the gold for us!
Jimmy—[Eagerly.] You say fella word, Captain, me kill um quick. They
no make plenty cry for schooner! They keep damn still plenty too much!
Bartlett—[Looking at the Islander with mad cunning but replying only
to Horne.] Aye, it’s good-bye to the gold, Horne. That scum of a cook—
he’s made a mock o’ us—sayin’ it wasn’t gold when he knew it was—he’ll
tell ’em—he’ll get joy o’ tellin’ ’em!
Horne—And that scrub of a boy—he’s no better. He’ll be in with him
neck and crop.
Cates—[Hoarsely.] Knife ’em—and be done with it—I say!
Bartlett—Or, if they don’t tell the schooner’s skipper it’ll only be
because they’re plannin’ to come back themselves—before we kin—and
dig it up. That cook—there’s somethin’ queer in his mind—somethin’ he
was hidin’—pretendin’ not to believe. What d’ye think, Horne?
Horne—I think—time’s gettin’ short—and talkin’ won’t do no good.
[Insinuatingly.] They’d do for us soon enough if they was able.
Bartlett—Aye, murder was plain in his eyes when he looked at me.
Horne—[Lowering his voice to a whisper.] Tell Jimmy—Captain
Bartlett—is what I say!
Bartlett—It’s agin the law, Silas Horne!
Horne—The law don’t reach to this island.
Bartlett—[Monotonously.] It’s against the law a captain’s sworn to
keep wherever he sails. They ain’t refused duty—nor mutinied.
Horne—Who’ll know they ain’t? They’re trying to steal what’s yours—
that’s worse’n mutiny. [As a final persuasion.] And Jimmy’s a nigger—and
under no laws. And he’s stronger’n you are. You couldn’t stop ’im.
Bartlett—Aye—I couldn’t prevent——
Jimmy—[Eagerly.] I fix um, Captain, they no tell! [Bartlett doesn’t
answer, but stares at the treasure. Horne makes violent motions to Jimmy to
go. The Islander stares at his master’s face. Then, seeming to read the direct
command there, he grunts with satisfaction, and pulling his knife from it’s
sheath, he goes stealthily off left. Cates raises himself on his haunches to
watch the Islander’s movements. Horne and Bartlett sit still in a strained
immobility, their eyes on the chest.]
Cates—[In an excited whisper.] I see ’em! They’re sittin’ with their
backs this way! [A slight pause.] There’s Jimmy. He’s crawlin’ on his hands
behind ’em. They don’t notice—he’s right behind—almost atop o’ them. [A
pause. Cates gives a fiendish grunt.] Ugh! [Butler’s muffled cry comes
from the left.] Right in the middle of the back! The cook’s done! The boy’s
runnin’! [There is a succession of quick screams from the boy, the padding
of feet running toward them, the fall of a body, and the boy’s dying groan.]
Horne—[With satisfaction.] It’s done, sir!
Bartlett—[Slowly.] I spoke no word, remember that, Silas Horne!
Horne—[Cunningly.] Nor me neither, sir. Jimmy took it on himself. If
blame there is—and who’d blame him for it?—it’s on him.
Bartlett—[Gloomily.] I spoke no word! [Jimmy returns noiselessly
from the left.]
Jimmy—[Grinning with savage pride.] I fix um fella plenty, Captain.
They no tell. They no open mouth plenty too much!
Cates—[Maudlinly.] You’re a man, Jimmy—a man with guts to him—
even if you’re a—— [He babbles incoherently.]
Jimmy—[As the Captain does not look at him.] I go climb fella tree,
Captain? I make look for schooner?
Bartlett—[Rousing himself with an effort.] Yes—go up. [The Islander
climbs the tree.]
Horne—[Getting to his feet—eagerly.] Where away, Jimmy?
Jimmy—She come, Captain, she come plenty quick.
Horne—[Looking in the direction Jimmy indicates.] I kin see her tops’ls
from here, sir. Look!
Bartlett—[Getting to his feet—stares out to sea.] Aye! There she be—
and makin’ towards us fast. [In a flash his sombre preoccupation is gone,
and he is commander once more. He puts the anklet in his hand into his
coat pocket—harshly.] Come down out o’ that? They’s work to do. [Jimmy
clambers down.] Did ye leave—them—lyin’ in plain sight on the open
sand?
Jimmy—Yes. I no touch um, Captain.
Bartlett—Then ye’ll touch ’em now. Go, bury ’em, cover ’em up with
sand. And mind ye make a good job o’ it that none’ll see. Jump now!
Jimmy—[Obediently.] I go, Captain. [He hurries off left.]
Bartlett—Down to the reef with ye, Horne! [Giving the prostrate
Cates a kick.] Up out o’ that, Cates! Go with Horne, and when ye see the
schooner hull up, wave to ’em, and yell like mad, d’ye hear?
Horne—Aye, aye, sir!
Bartlett—I’ll stay here and bury the gold. It’s best to be quick about it!
They may turn a spyglass on us when they raise the island from deck! Off
with ye! [He gives Cates another kick.]
Cates—[Groaning.] I’m sick! [Incoherently.] Can’t—report for duty—
this watch. [With a shout.] Water!
Bartlett—[Contemptuously.] Ye dog! Give him a hand, Horne.
Horne—[Putting a hand under his shoulder.] Up, man! We’re to signal
the schooner. There’ll be water on board o’ her—barrels of it!
Cates—[Aroused, scrambles to his feet, violently shaking off Horne’s
hand.] Water aboard o’ her! [His staring eyes catch the schooner’s sails on
the horizon. He breaks into a staggering run and disappears down toward
the beach, right rear, waving his arms wildly and shouting.] Ahoy! Ahoy!
Water! [Horne walks out quickly after him.] [Left alone, Bartlett, after a
quick glance around, sinks on his knees beside the chest and shoves both
hands into it. From the chest comes a metallic clink as he fingers the pieces
in his hands gloatingly.] Ye’re safe now! There’s none to tell left livin’!
He’s dead—damn him!—that lied about ye. And ye’ll rest safe here till I
come back for ye! [In a dreaming tone, his eyes fixed before him in an
ecstatic vision.] No more whalin’ on the dirty seas! Rest to home! Gold!
I’ve been dreamin’ o’ it all my life! Aye—we’ll rest now, Sarah! Your father
be a rich man, Nat and Sue! [Shaking himself—savagely.] Ye fool! What
drivel be ye talkin’? Loosin’ your senses, be ye? Time ye was picked up!
Lucky! [He shoves down the lid and places the chest in the hole. He pushes
the sand in on top of it, whispering hoarsely.] Lay safe, d’ye hear. For I’ll
be back for ye! Aye—in spite of hell I’ll dig ye up again! [The voices of
Horne and Jimmy can be heard from the distance shouting as